Cargando…

Fabry Disease – Underestimated in the Differential Diagnosis of Multiple Sclerosis?

OBJECTIVE: Fabry disease is a rare X-linked inherited lysosomal storage disorder affecting multiple organ systems. It includes central nervous system involvement via micro- and macroangiopathic cerebral changes. Due to its clinical symptoms and frequent MRI lesions, Fabry disease is commonly misdiag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Böttcher, Tobias, Rolfs, Arndt, Tanislav, Christian, Bitsch, Andreas, Köhler, Wolfgang, Gaedeke, Jens, Giese, Anne-Katrin, Kolodny, Edwin H., Duning, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756019/ https://www.ncbi.nlm.nih.gov/pubmed/24015197 http://dx.doi.org/10.1371/journal.pone.0071894

Ejemplares similares

Continuous Cardiac Troponin I Release in Fabry Disease
por: Feustel, Andreas, et al.
Publicado: (2014)

Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease
por: Lukas, Jan, et al.
Publicado: (2013)

Persistent increase in cardiac troponin I in Fabry disease: a case report
por: Tanislav, Christian, et al.
Publicado: (2011)

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2016)

Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease
por: Tanislav, Christian, et al.
Publicado: (2016)

Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene
por: Lukas, Jan, et al.
Publicado: (2012)

C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease
por: Cozma, Claudia, et al.
Publicado: (2017)

Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease
por: Seemann, Susanne, et al.
Publicado: (2020)

Idiopathic Small Fiber Neuropathy: Phenotype, Etiologies, and the Search for Fabry Disease
por: Samuelsson, Kristin, et al.
Publicado: (2014)

Bridging the Gap Between Vessels and Nerves in Fabry Disease
por: Forstenpointner, Julia, et al.
Publicado: (2020)

The patient journey of patients with Fabry disease, Gaucher disease and Mucopolysaccharidosis type II: A German-wide telephone survey
por: Mengel, Eugen, et al.
Publicado: (2020)

Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis
por: Ugga, Lorenzo, et al.
Publicado: (2018)

Lessons from everyday stroke care for clinical research and vice versa: comparison of a comprehensive and a research population of young stroke patients
por: Tanislav, Christian, et al.
Publicado: (2014)

Diagnosis of Morquio Syndrome in Dried Blood Spots Based on a New MRM-MS Assay
por: Cozma, Claudia, et al.
Publicado: (2015)

MULTIPLE SCLEROSIS OR FABRY DISEASE – PROS AND CONS
por: Zavoreo, Iris, et al.
Publicado: (2018)

Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS)
por: De Bondt, Mirre, et al.
Publicado: (2020)

Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis
por: Cohan, Stanley, et al.
Publicado: (2015)

Genotype–Phenotype Correlation in a New Fabry-Disease-Causing Mutation
por: Čerkauskaitė, Agnė, et al.
Publicado: (2019)

Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease
por: Lukas, Jan, et al.
Publicado: (2020)

Excessive Daytime Sleepiness Is a Common Symptom in Fabry Disease
por: Duning, Thomas, et al.
Publicado: (2009)

Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease
por: Wagner, Martin, et al.
Publicado: (2014)

Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients
por: Rolfs, Arndt, et al.
Publicado: (2013)

Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Münster Study (FaMüS) data
por: Engelen, Markus A, et al.
Publicado: (2012)

Erythropoietin and the effect of oxygen during proliferation and differentiation of human neural progenitor cells
por: Giese, Anne-Katrin, et al.
Publicado: (2010)

Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
por: Lenders, Malte, et al.
Publicado: (2013)

Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease
por: Pogoda, Christian, et al.
Publicado: (2023)

Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs
por: Colomba, Paolo, et al.
Publicado: (2018)

Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease
por: Rath, Jakob, et al.
Publicado: (2022)

Case Report: A Spinal Ischemic Lesion in a 24-Year-Old Patient With Fabry Disease
por: Krämer, Julia, et al.
Publicado: (2020)

Diagnosis and Screening of Patients with Fabry Disease
por: Vardarli, Irfan, et al.
Publicado: (2020)

Eight-Year Follow-Up of Neuropsychiatric Symptoms and Brain Structural Changes in Fabry Disease
por: Lelieveld, Irene M., et al.
Publicado: (2015)

Value of Left Ventricular Feature Tracking Strain Analysis for Detection of Early Cardiac Involvement in Fabry Disease (FD)
por: Roller, Fritz Christian, et al.
Publicado: (2021)

Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis
por: Lahmer, Tobias, et al.
Publicado: (2016)

Sinoatrial conduction abnormalities – an underestimated cardiac complication in women with systemic sclerosis
por: Kramarz, Elżbieta, et al.
Publicado: (2021)

Cerebral vein thrombosis: clinical manifestation and diagnosis
por: Tanislav, Christian, et al.
Publicado: (2011)

Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
por: Lenders, Malte, et al.
Publicado: (2016)

Clinical signs in young patients with stroke related to FAST: results of the sifap1 study
por: Kaps, Manfred, et al.
Publicado: (2014)

Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related GLA-Variant p.A143T
por: Godel, Tim, et al.
Publicado: (2020)

Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis
por: Deppe, Michael, et al.
Publicado: (2014)

Ovarian Manson's Schistosomiasis: Rare Diagnosis or Underestimated Prevalence?
por: Gomes, Elainne Christine de Souza, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9n9p10s8v33qprrvbdgni3de4n